Hormone replacement therapy-induced pain and redness of the feet.
Lu J, Lu Y
Clinical and experimental dermatology •
We report the first case, to our knowledge, of a patient who developed erythromelalgia after receiving oestrogen-progestin replacement therapy (Femoston). The patient had complete remission after taking glycyrrhizin and pregabalin for 3 months. This case expands the spectrum of erythromelalgia and provides a therapeutic option.